An Engineered Channelrhodopsin Optimized for Axon Terminal Activation and Circuit Mapping
ARTICLE https://doi.org/10.1038/s42003-021-01977-7 OPEN An engineered channelrhodopsin optimized for axon terminal activation and circuit mapping Shun Hamada 1,5, Masashi Nagase2,5, Tomohiko Yoshizawa 3,4,5, Akari Hagiwara 1,5, ✉ ✉ ✉ Yoshikazu Isomura 3,4 , Ayako M. Watabe 2 & Toshihisa Ohtsuka 1 Optogenetic tools such as channelrhodopsin-2 (ChR2) enable the manipulation and mapping of neural circuits. However, ChR2 variants selectively transported down a neuron’s long- range axonal projections for precise presynaptic activation remain lacking. As a result, ChR2 activation is often contaminated by the spurious activation of en passant fibers that com- promise the accurate interpretation of functional effects. Here, we explored the engineering 1234567890():,; of a ChR2 variant specifically localized to presynaptic axon terminals. The metabotropic glutamate receptor 2 (mGluR2) C-terminal domain fused with a proteolytic motif and axon- targeting signal (mGluR2-PA tag) localized ChR2-YFP at axon terminals without disturbing normal transmission. mGluR2-PA-tagged ChR2 evoked transmitter release in distal projection areas enabling lower levels of photostimulation. Circuit connectivity mapping in vivo with the Spike Collision Test revealed that mGluR2-PA-tagged ChR2 is useful for identifying axonal projection with significant reduction in the polysynaptic excess noise. These results suggest that the mGluR2-PA tag helps actuate trafficking to the axon terminal, thereby providing abundant possibilities for optogenetic experiments. 1 Department of Biochemistry, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. 2 Institute of Clinical Medicine and Research, Research Center for Medical Sciences, The Jikei University School of Medicine, Chiba, Japan. 3 Department of Physiology and Cell Biology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
[Show full text]